Clinical Trials Logo

Hypertrophy clinical trials

View clinical trials related to Hypertrophy.

Filter by:

NCT ID: NCT04418297 Terminated - Clinical trials for Cardiomyopathy, Hypertrophic Obstructive

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Start date: October 23, 2020
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, sequential, 5-day treatment, ascending dose study in subjects with obstructive HCM aged 18-70 years. The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of CT-G20.

NCT ID: NCT04411173 Completed - Hypertrophy Clinical Trials

Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations

Start date: September 12, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the ability of isocaloric and isonitrogenous (2 x 15-gram) doses of rice protein or whey protein to stimulate resistance training adaptations in young, healthy, resistance-trained men.

NCT ID: NCT04402268 Completed - Clinical trials for Hypertrophic Cardiomyopathy

Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy

Start date: October 1, 2014
Phase:
Study type: Observational

Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is most often caused by mutations in sarcomere genes. The structural and functional abnormalities cannot be explained by flow-limiting coronary artery disease or loading conditions. The disease affects at least 0,2% of the population worldwide and is the most common cause of sudden cardiac death (SCD) in young people and competitive athletes due to fatal ventricular arrhythmia, but in most patients, however, HCM has a benign course. Therefore, it is of utmost importance to properly evaluate patients and identify those who would benefit from a cardioverter-defibrillator (ICD) implantation.

NCT ID: NCT04398420 Terminated - Clinical trials for Benign Prostatic Hypertrophy

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

Start date: August 27, 2020
Phase: N/A
Study type: Interventional

To verify the safety and efficacy of the use of the plasma vaporisation button in Transurethral Vapor Enucleation and Resection of the prostate (TVERP) for treatment of Benign prostatic hypertrophy (BPH) patients with prostate ˃30 and ≤80 ml compare to TURis or HoLEP surgery methods.

NCT ID: NCT04389619 Active, not recruiting - Hypertrophic Scars Clinical Trials

Fractional Microneedling RF vs Intralesional Steroid With & Without Microneedling in Hypertrophic Scars

Start date: May 10, 2020
Phase: N/A
Study type: Interventional

Comparing between the effect of Fractional Microneedling Radiofrequency Versus Intralesional Steroid Injection with and without Microneedling on Tissue levels of PDGF & CTGF in Hypertrophic Scars

NCT ID: NCT04386772 Recruiting - Clinical trials for Hepatocellular Carcinoma

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Start date: May 27, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the differences of safety and liver hypertrophy between portal vein embolization (PVE) using coils plus tris-acryl gelatin microspheres (TAGM) and multiple coils in patients with perihilar cholangiocarcinoma (pCCA) or with hepatocellular carcinoma (HCC).

NCT ID: NCT04381390 Completed - Hypertrophy Clinical Trials

Egg Consumption and Muscular Adaptations

Start date: September 10, 2018
Phase: N/A
Study type: Interventional

Eggs may be a viable alternative to various types of supplemental proteins given its similar ratings on various measures of dietary protein quality. The investigators hypothesis is that whole eggs would create a greater improvement in skeletal regulatory markers, hormonal responses and body composition than egg white ingestion in resistance-trained men.

NCT ID: NCT04380272 Completed - Clinical trials for Obstructive Tonsillar Hypertrophy

Development of an Assessment Method for Obstructive Tonsillar Hypertrophy in Children by Ultrasonography

Start date: January 1, 2019
Phase:
Study type: Observational

Chronic tonsillar hypertrophy is one of the most common causes of upper airway obstruction in children. Currently, several clinical staging systems are used to evaluate airway obstruction due to tonsillar hypertrophy. However, as these staging systems are based on a physical examination, it is not always possible to accurately evaluate the tonsil size, especially in children, and so objective and reliable methods are required in this field. In this study, the investigators aimed to develop a new method for the objective evaluation of airway obstruction due to tonsillar hypertrophy using submental ultrasonography (US) in children.

NCT ID: NCT04376320 Completed - Clinical trials for Alveolar Ridge Enlargement

Comparison of Two Pre-prosthetic Surgical Techniques for Augmentation of Mandibular Vertical Ridge Defects

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to compare two pre-prosthetic surgical techniques for augmentation of vertical mandibular ridge defects in preparation for implant placement, the first using customized ceramic membranes and the second using tenting titanium screws in conjunction with particulate bone graft and collagen membrane (modified sausage technique).

NCT ID: NCT04370132 Completed - Major Hepatectomy Clinical Trials

Segment IV Hypertrophy After Liver Venous Deprivation

Start date: January 1, 2015
Phase:
Study type: Observational

before major hepatectomy, in case of insufisant future liver remanent volume or function, portal embolization is a routinely used method to enable growth of the future liver remnant. Recently liver venous deprivation has been described in some pioneer centre. The results are processing with greater and faster hypertrophy allowing probably less drop out from the embolization to surgery compared to portal embolization. In major hepatectomy, and specially in right or extended right hepatectomy the segment IV plays an important role in the proportion of future liver remnant. Despite the growing interest in the scientific community for liver venous deprivation many aspects concerning the liver hypertrophy remains unexplored. In particular the the degree of hypertrophy of segment IV after liver venous deprivation compared to portal embolization.